Clinical Trials Logo
  1. Home
  2. Juvenile Rheumatoid Arthritis
  3. NCT00690573

Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid Arthritis

Juvenile Rheumatoid Arthritis Clinical Trial

Official title:
A Multicenter, Open-label Study of the Safety, Efficacy, and Pharmacokinetics of the Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Rheumatoid Arthritis

Clinical Trial Summary

To evaluate efficacy, safety and pharmacokinetics of adalimumab in Japanese children with Polyarticular Juvenile Rheumatoid Arthritis

Clinical Trial Description

This was an open-label long-term study that was completed following study drug approval in Japan for the treatment of JRA. Data are presented through Week 144 and for the final visit. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00690573
Study type Interventional
Source Abbott
Contact
Status Completed
Phase Phase 3
Start date May 2008
Completion date September 2011
View Details
See also
  Status Clinical Trial Phase
Completed NCT00004420 - Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis N/A
Completed NCT00090571 - Juvenile Rheumatoid Arthritis Research Registry
Recruiting NCT05545839 - Transition to Adulthood Through Coaching and Empowerment in Rheumatology N/A
Completed NCT00010335 - Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders Phase 1
Completed NCT00443430 - Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis Phase 4
Completed NCT03780959 - Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA) Phase 2/Phase 3
Active, not recruiting NCT00006055 - Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases N/A
Completed NCT00570934 - Supplementation With Vitamin D, Calcium or Both on Calcium Absorption and Bone Mineral Content in Children With JRA Phase 3
Recruiting NCT05715463 - Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity N/A
Completed NCT00289094 - Randomized Fixed Bearing vs Mobile Bearing Cruciate Retaining TKA N/A
Terminated NCT00078806 - Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis Phase 3
Completed NCT00078793 - Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis N/A
Completed NCT00000429 - Calcium Supplements for Bone Health in Juvenile Rheumatoid Arthritis Phase 2
Completed NCT01044823 - Use of Thermal and 3D Imaging to Quantify Arthritis N/A
Terminated NCT00029042 - Infliximab to Treat Children With Juvenile Rheumatoid Arthritis Phase 2
Withdrawn NCT00286689 - Effects of Growth Hormone in Chronically Ill Children N/A
Completed NCT00095173 - BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis Phase 3
Completed NCT00001862 - TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis Phase 2
Not yet recruiting NCT05114343 - Effectiveness and Feasibility of a Home-based Exercise Program for Adolescents With Juvenile Idiopathic Arthritis N/A
Terminated NCT03781375 - Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid Arthritis Phase 3